Breast Neoplasms: all 12,828 studies

Page 75 of 129. Open to participants first (2,932), then studies with results posted, then the rest; newest registration first within each.

• Clinical Outcome and Toxicity Data in Patients With Advanced Breast Cancer Treated With CDK Inhibitors Combined With Endocrine TherapyCompletedNCT04133207
• Study of DS-8201a, an Antibody Drug Conjugate for Advanced Breast Cancer Patients, With Biomarkers AnalysisCompletedNCT04132960Phase 2
• A Study of Multiple Immune and Disease Treatment Combinations in Participants With ER+HER2- Breast Cancer That Has SpreadCompletedNCT04132817Phase 1
• The Consistency of Drug Screening in Vitro and Neoadjuvant Chemotherapy Results in Breast Cancer PatientsCompletedNCT04131881
• A Trial of Camrelizumab in Combination With Nab-paclitaxel and Famitinib as a First Line Treatment in Patients With Unresectable Locally Advanced or Metastatic Immunomodulatory Triple Negative Breast Cancer(FUTURE-C-PLUS)Status unknownNCT04129996Phase 2
• Adjuvant 6 Cycles of Docetaxel and Cyclophosphamide or 3 Cycles of Cyclophosphamide/Epirubicin/Fluorouracil Followed by 3 Cycles of Docetaxel Versus 4 Cycles of Epirubicin and Cyclophosphamide Followed by Weekly Paclitaxel in Operable Breast Cancer (MASTER)CompletedNCT04127019Phase 3
• Stochastic Modulated Vibrations on Autonomic Nervous System of Breast Cancer Patients During RadiotherapyStatus unknownNCT04125953Not applicable
• The SONImage StudyActive, not recruitingNCT04125277Not applicable
• Fibrotic Focus in Breast CancerStatus unknownNCT04122131
• Effects of Exercise in Patients With Metastatic Breast CancerActive, not recruitingNCT04120298Not applicable
• Alpha-TEA and Trastuzumab for the Treatment of Refractory HER2+ Metastatic Breast CancerSuspendedNCT04120246Phase 1
• Feasibility and Accuracy of Nanosensor-based Cancer Diagnosis at the Point-of-care (Chedza)CompletedNCT04119154Not applicable
• NOSTRA-Feasibility Study: A Study Looking at Ultrasound Guided Biopsies for Breast CancerActive, not recruitingNCT04118192
• Tell us Your Food StoryWithdrawnNCT04117438
• Sleep and Activity Patterns in Pre-menopausal Breast Cancer Patients on Tamoxifen Using a Wrist-worn Internet of Things DeviceStatus unknownNCT04116827
• Focused Ultrasound Ablation and PD-1 Antibody Blockade in Advanced Solid TumorsTerminatedNCT04116320Phase 1
• Short and Long Term Effects of a Physical Therapy Program After Breast Cancer SurgerySuspendedNCT04116281Not applicable
• Effectiveness of a Cream for Treatment of Dermatitis in Patients Whith Breast CancerCompletedNCT04116151Not applicable
• Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast CancerActive, not recruitingNCT04115306Phase 1/2
• Lymphedema Prevention in Breast CancerCompletedNCT04112966Not applicable
• Effect of a Program of Physical Activity and Nutritional Therapeutic Education in Breast Cancer PatientsCompletedNCT04109326Not applicable
• Implementing Exercise Into Clinical Practice in Breast Cancer CareCompletedNCT04109274Not applicable
• Analysis of Palbociclib Treatment in Patients With Advanced Breast Cancer Within a Compassionate Use ProgrameCompletedNCT04109261
• Surgical and Oncologic Outcomes After Robotic Nipple Sparing Mastectomy and Immediate ReconstructionCompletedNCT04108117
• Minimal Invasive Breast Cancer Excision Using Vacuum Assisted Biopsy Under Ultrasound GuidanceCompletedNCT04107636Not applicable
• Breast Cancer Neoantigen Vaccination With Autologous Dendritic CellsCompletedNCT04105582Phase 1
• Safety, Tolerability, and Pharmacokinetics of Proxalutamide Therapy in Women With Metastatic Breast CancerCompletedNCT04103853Phase 1
• Safety and Performance of the Multi-Modal UltraSound Tomography (MUST) Device in Breast Cancer ScreeningStatus unknownNCT04102722Not applicable
• A Window-of-opportunity Study of Pelareorep in Early Breast CancerTerminatedNCT04102618Early Phase 1
• Omission of SLNB in Triple-negative and HER2-positive Breast Cancer Patients With rCR and pCR in the Breast After NASTActive, not recruitingNCT04101851Not applicable
• Highly Accelerated Dose-Integrated Radiotherapy in 5 Fractions in Breast CancerCompletedNCT04098926Not applicable
• Health Belief Model Based Nursing Interventions on Lymphedema PreventionCompletedNCT04098783Not applicable
• A Phase I Study of LX-039 TabletsCompletedNCT04097756Phase 1
• A Phase Ⅱ Trial of Pyrotinib Combination With CDK4/6 Inhibitor SHR6390 in Patients Prior Trastuzumab-treated Advanced HER2-Positive Breast CancerStatus unknownNCT04095390Phase 2
• TCHP Versus EC -THP as Neoadjuvant Treatment for HER2-Positive Breast CancerStatus unknownNCT04094896Phase 2
• XIST Gene Deletion in Breast Cancer TherapyStatus unknownNCT04093609
• Hyperventilation and Oxygenation to Prolong Breath Hold in Breast Cancer Irradiation TreatmentCompletedNCT04091542Not applicable
• Vitamin D Supplementation to Correct the Vitamin D Deficiency for Breast CancerCompletedNCT04091178Phase 2
• Rise Up After Breast CancerCompletedNCT04088877Not applicable
• Gut Microbe Composition, Exercise, and Breast Breast Cancer SurvivorsActive, not recruitingNCT04088708Not applicable
• Xoft® Intraoperative Radiotherapy (IORT) for Patients With Early-Stage Breast CancerTerminatedNCT04088435
• Pyrotinib Combined With Trastuzumab Plus Aromatase Inhibitor in Treatment of Breast CancerStatus unknownNCT04088110Phase 2
• Neoadjuvant Study of Abemaciclib, Durvalumab, and an Aromatase Inhibitor Early Stage Breast CancerWithdrawnNCT04088032Early Phase 1
• Barriers Associated With Timely Adjuvant Chemotherapy Administration in Patients With Invasive Breast CancerCompletedNCT04087057
• A Text-based Intervention in Improving Adherence to Hormone Therapy in Patients With Stage I-III Hormone Receptor Positive Breast CancerActive, not recruitingNCT04086875Not applicable
• Tomosynthesis vs. Contrast-Enhanced Mammography in Women With Personal History of Breast Cancer in Western PennsylvaniaActive, not recruitingNCT04085510Not applicable
• Effects of Manual Therapy on Chronic Pain and Functionality of Breast Cancer SurvivorsTerminatedNCT04084600Not applicable
• Non-mass Enhancement in Breast MRICompletedNCT04083027
• LASER and Radiofrequency for Treatment of Vaginal Vulvar Atrophy (VVA) in Women Treated for Breast Cancer (EPMLARF-arm2)Active, not recruitingNCT04081805Not applicable
• Survivorship Care Plans and Telehealth Education for the Improvement of Access to Cancer Survivorship, the IMPACT StudyCompletedNCT04081779Not applicable
• Reliability and Reproducibility of Bandaging in Breast CancerCompletedNCT04076033Not applicable
• Pain, Psychological, and Endocannabinoid Responses to Yoga in Breast Cancer Survivors With Chemotherapy-induced Neuropathic PainCompletedNCT04075097Not applicable
• Hypofractionated Radiation Therapy in Patients With Breast CancerCompletedNCT04075058Phase 3
• Volatile Anaesthesia and Perioperative Outcomes Related to Cancer Feasibility StudyCompletedNCT04074460Phase 4
• Simultaneous Integrated Boost With Volumetric Arc Radiotherapy in Patients With Breast CancerCompletedNCT04072718Phase 2
• Taxane Induced Peripheral Neuropathy in Chinese Patients With Breast CancerStatus unknownNCT04068090
• Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV CancerCompletedNCT04067960Early Phase 1
• Nab-paclitaxel Based Regimens VS Paclitaxel Based Regimens in Neoadjuvant Treatment for TNBCWithdrawnNCT04067102Not applicable
• Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast CancerTerminatedNCT04066790Phase 2
• Nivolumab and Eribulin in HER2 Negative Metastatic Breast CancerStatus unknownNCT04061863Phase 1/2
• FSRT in Breast Cancer Patients With Brain MetastasesStatus unknownNCT04061408Phase 2
• OptiBra Study, Optimal Postoperative Bra After Breastcancer SurgeryStatus unknownNCT04059835Phase 3
• Photobiomodulation for Breast Cancer RadiodermatitisCompletedNCT04059809Phase 2/3
• CTC Changes and Efficacy of Neoadjuvant Chemotherapy for Triple-negative Breast CancerStatus unknownNCT04059003
• Specialist Recommendation on FBC (Familial Breast Cancer) Chemoprevention PrescribingCompletedNCT04058418
• Analgesic Effect of Adding Thoracic Paravertebral Nerve Blocks to Modified PEC Block in Breast Cancer SurgeryStatus unknownNCT04056676Not applicable
• Adj. Marker-adjusted Personalized Therapy Comparing ET+Ribociclib vs Chemotherapy in Intermediate Risk, HR+/HER2- EBCActive, not recruitingNCT04055493Phase 3
• Study of the Imaging Agent 18F-Var3 in Patients With Breast CancerCompletedNCT04054986Phase 1
• Vaccine Response With NT-I7WithdrawnNCT04054752Phase 1
• Patient Reported Outcomes, Smart Pill Bottle and Teleheath for Endocrine Therapy AdherenceCompletedNCT04054557Not applicable
• Testing the Addition of an Anti-cancer Drug, Berzosertib, to the Usual Treatment (Radiation Therapy) for Chemotherapy-Resistant Triple-Negative and Estrogen and/or Progesterone Receptor Positive, HER2 Negative Breast CancerActive, not recruitingNCT04052555Phase 1
• Improving Cognition After CancerActive, not recruitingNCT04049695Not applicable
• Robotic Versus Conventional or Endoscopic Nipple Sparing Mastectomy for Breast CancerStatus unknownNCT04049305Not applicable
• Temperature and Injury in Radiotherapy Radiation Skin InjuryStatus unknownNCT04047823
• Palbociclib Combined With an Aromatase Inhibitor in Breast CancerStatus unknownNCT04047758Phase 3
• Early Detection of Cardiac Damage With CMR in Women With Breast CancerStatus unknownNCT04046315
• Study on Bisphosphonates Targeting Triple-negative Breast CancerStatus unknownNCT04045522
• A First-in-Human, Phase 1 Study of JAB-3312 in Adult Patients With Advanced Solid TumorsCompletedNCT04045496Phase 1
• Effects of Mediterranean Diet Based Intervention in Breast Cancer PatientsStatus unknownNCT04045392Not applicable
• Effect of Sukshma Vyayama Yoga on Aromatase Inhibitor-Induced Arthralgia in Breast Cancer SurvivorsCompletedNCT04042870Not applicable
• DS8201a and Pembrolizumab in Participants With Locally Advanced/Metastatic Breast or Non-Small Cell Lung CancerActive, not recruitingNCT04042701Phase 1
• A Study of SGN-CD228A in Advanced Solid TumorsTerminatedNCT04042480Phase 1
• Microvascular Function in Patients Undergoing 5-Fluorouracil ChemotherapyCompletedNCT04042298
• Copanlisib in Combination With T-DM1 in Pretreated Unresectable Locally Advanced or Metastatic HER2-positive Breast CancerTerminatedNCT04042051Phase 1
• PARP Inhibition During Pre-surgical Window in Breast/Ovary CancerCompletedNCT04041128Early Phase 1
• HER2 Expression Detection in Breast Cancer Using 99mTc-NM-02CompletedNCT04040686Early Phase 1
• A Phase I Dose Escalation Study of Single Fraction Pre-operative Partial Breast (S-PBI) for Early Stage Breast CancerActive, not recruitingNCT04040569Phase 1
• MUltimodal Targeted Axillary SurgeryStatus unknownNCT04039893Not applicable
• Study to Evaluate Sacituzumab Govitecan in Combination With Talazoparib in Patients With Metastatic Breast Cancer.Active, not recruitingNCT04039230Phase 1/2
• SEINIOR:Quality of Life and Breast Cancer in Older WomenStatus unknownNCT04038606Not applicable
• COX Inhibition and Biomarkers During Neoadjuvant Chemoendocrine Therapy for ER+, HER2- Stage I-III Breast CancerWithdrawnNCT04038489Phase 2
• Robotic Versus Conventional or Endoscopic Nipple Sparing Mastectomy in the Management of Breast Cancer-Prospective StudyStatus unknownNCT04037852Not applicable
• Facial Skin Health Tracking Feasibility in Breast Cancer PatientsWithdrawnNCT04035408
• KN035 in Combination With Trastuzumab and Docetaxel in HER2-positive Breast CancerStatus unknownNCT04034823Phase 2
• Pyrotinib in Combination With Fulvestrant in Patients With HER2 Positive，HR-Positive Metastatic Breast CancerStatus unknownNCT04034589Phase 2
• Corellation of Mutations, TILs and Age in Breast CancerCompletedNCT04033965
• Pyrotinib Plus Fulvestrant in Patients With HR+/HER2+ Metastatic Breast Cancer (Pyrotinib+Fulvestrant )Status unknownNCT04033172Phase 2
• Study Comparing Paclitaxel Plus Carboplatin Versus Anthracyclines Followed by Docetaxel as Adjuvant Chemotherapy for Triple Negative Breast Cancer (PATTERN)CompletedNCT04031703Phase 3
• Neoadjuvant DatabaseStatus unknownNCT04031612
• Patient Report Outcome-Reconstruction and Oncoplastic CohortStatus unknownNCT04030845

← Breast Neoplasms overview